05 Nov R3 Stem Cell’s Response to the FDA Warning Letter: What Patients and Families Should Know
By Dr. David Greene, MD, PhD, MBA, Founder and CEO of R3 Stem Cell If you’re considering regenerative treatment with R3 Stem Cell, you may have seen news about a warning letter the U.S. Food and Drug Administration (FDA) sent us in August 2026. Some of...





